Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 15, 2008 (Vol. 28, No. 8)

Cell-Based Assay R&D Role Expands

Automation, Label-Free Tools, and Other Innovations Create Better Screening

  • Cell-based assays have become a quick, lower-cost means of testing drug candidates for toxic effects in early discovery work. Informa Life Sciences’ upcoming “Cell-Based Assays” meeting will highlight some advances that are driving the field such as improved screening technologies, noninvasive monitoring, and the increasingly important incorporation of automation. ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.